Statins and the progression of age-related macular degeneration in the United States.
<h4>Purpose</h4>To study the effect of statin exposure on the progression from non-exudative to exudative age-related macular degeneration (AMD).<h4>Methods</h4>Retrospective cohort study of commercially insured patients diagnosed with non-exudative AMD (n = 231,888) from 200...
Guardado en:
Autores principales: | Cassie A Ludwig, Daniel Vail, Nitya A Rajeshuni, Ahmad Al-Moujahed, Tatiana Rosenblatt, Natalia F Callaway, Malini Veerappan Pasricha, Marco H Ji, Darius M Moshfeghi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/07271a77698a4554bd865cfc52fe3329 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Key factors in a rigorous longitudinal image-based assessment of retinopathy of prematurity
por: Tatiana R. Rosenblatt, et al.
Publicado: (2021) -
The controversy over the association between statins use and progression of age-related macular degeneration: a mini review
por: Vasileios Peponis, et al.
Publicado: (2010) -
Can HMG Co-A reductase inhibitors (“statins”) slow the progression of age-related macular degeneration? The Age-Related Maculopathy Statin Study (ARMSS)
por: Robyn H Guymer, et al.
Publicado: (2008) -
Telemedicine Follow-Up for Intravitreal Bevacizumab Injection in the Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP) Cohort
por: Ji MH, et al.
Publicado: (2020) -
Age-related macular degeneration
por: Querques G, et al.
Publicado: (2011)